Overview
Latonya Riddle-Jones is a primary care provider, practicing in Pediatrics and Internal Medicine in Detroit, Michigan. Dr. Riddle-Jones is rated as an Experienced provider by MediFind in the treatment of Bronchiectasis. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Chronic Cough, and Myelitis. Dr. Riddle-Jones is currently accepting new patients.
Her clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brian Fedoronko is a primary care provider, practicing in Pediatrics and Internal Medicine in Ann Arbor, Michigan. Dr. Fedoronko is rated as an Experienced provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Bronchiectasis and Type 2 Diabetes (T2D). Dr. Fedoronko is currently accepting new patients.
Regents Of The University Of Michigan
Donald Martin is a primary care provider, practicing in Pediatrics and Internal Medicine in Ann Arbor, Michigan. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Vertigo, and Chronic Cough. Dr. Martin is currently accepting new patients.
Regents Of The University Of Michigan
Carey Lumeng is a Pediatric Pulmonologist and a Pulmonary Medicine provider in Ann Arbor, Michigan. Dr. Lumeng is rated as an Advanced provider by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Secondary Immunodeficiency (SID), Cystic Fibrosis, Newborn Jaundice, Trisomy 13, and Adenoidectomy. Dr. Lumeng is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic CoughDr. Riddle-Jones isAdvanced. Learn about Chronic Cough.
- Chronic Obstructive Pulmonary Disease (COPD)Dr. Riddle-Jones isAdvanced. Learn about Chronic Obstructive Pulmonary Disease (COPD).
- Lung MetastasesDr. Riddle-Jones isAdvanced. Learn about Lung Metastases.
- Experienced
- Acquired HemophiliaDr. Riddle-Jones isExperienced. Learn about Acquired Hemophilia.
- Acute CystitisDr. Riddle-Jones isExperienced. Learn about Acute Cystitis.
- Acute Interstitial PneumoniaDr. Riddle-Jones isExperienced. Learn about Acute Interstitial Pneumonia.
- AIDS Dementia ComplexDr. Riddle-Jones isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Riddle-Jones isExperienced. Learn about AIDS Dysmorphic Syndrome.
- ALK-Positive Non-Small Cell Lung CancerDr. Riddle-Jones isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.